Abstract: Methods of dyeing a material, comprising treating the material with a dyeing system which comprises (a) one or more mono-, di- or polycyclic aromatic or heteroaromatic compounds, and (b) (i) a hydrogen peroxide source and an enzyme exhibiting peroxidase activity or (ii) an enzyme exhibiting oxidase activity on the one or more aromatic or heteroaromatic compounds; wherein the material is a fabric, yarn, fiber, garment or film made of cotton, diacetate, flax, linen, lyocel, polyacrylic, synthetic polyamide, polyester, ramie, rayon, tencel, or triacetate.
Type:
Grant
Filed:
December 19, 1996
Date of Patent:
October 26, 1999
Assignees:
Novo Nordisk A/S, Novo Nordisk Bio-Chem North America
Abstract: The present invention relates to a liquid composition comprising an enzyme and a phenyl boronic acid derivative enzyme stabilizer of the following formula: ##STR1## wherein R is selected from the group consisting of hydrogen, hydroxy, C.sub.1 -C.sub.6 alkyl, substituted C.sub.1 -C.sub.6 alkyl, C.sub.1 -C.sub.6 alkenyl and substituted C.sub.1 -C.sub.6 alkenyl.
Abstract: A needle unit comprises a needle mounted in a hub having a sleeve made from a deformable material and surrounding an end of the needle at a radial distance from that needle. The sleeve is designed to be snap-locked onto a connecting piece at the outlet end of a syringe by protrusions on the inner wall of the sleeve engaging a circumferential recess in the outer wall of the connecting piece. It is also designed such that the locking engagement between the protrusions of this sleeve and the recess of the connecting piece is released when certain zones of the outer sleeve wall are pressed inwardly. A magazine for storing the needle unit comprises a compartment which can receive the needle unit in a plurality of rotational positions.
Abstract: The present invention relates to a novel method for treating a mammal suffering from or susceptible to schizophrenia and schizophreniform diseases.
Type:
Grant
Filed:
June 5, 1995
Date of Patent:
October 19, 1999
Assignee:
Novo Nordisk A/S
Inventors:
Franklin Porter Bymaster, Harlan E. Shannon, Per Sauerberg, Preben Olesen, John Stanley Ward, Charles H. Mitch
Abstract: The invention relates to a liquid composition which comprises an enzyme and a enzyme stabilizing component. The enzyme stabilizing component is a boronic acid derivative.
Abstract: The invention deals with a process for providing a cellulosic material, such as a fabric or a paper and pulp product, with improved strength and/or shape-retention and/or anti-wrinkling properties, the process comprising contacting, in an aqueous medium, the cellulosic material with a xyloglucan endotransglycosylase (XET).
Abstract: The present invention relates to novel host cells and to methods of producing proteins. More specifically the invention relates to a host cell useful for the expression of heterologous proteins, which host cell has been genetically modified in order to express significantly reduced levels of a metalloprotease. Moreover the invention relates to a method of producing a heterologous protein, which method comprises cultivating the host cell in a suitable growth medium, followed by recovery of the desired protein.
Abstract: The present invention relates to Curvularia verruculosa haloperoxidases and isolated nucleic acid fragments comprising nucleic acid sequences encoding the haloperoxidases as well as nucleic acid constructs, vectors, and recombinant host cells comprising the nucleic acid sequences. The invention also relates to methods for recombinant production of the haloperoxidase. The invention further relates to compositions comprising the haloperoxidases and methods of using the compositions for killing microbial cells or inhibiting growth of microbial cells.
Type:
Grant
Filed:
April 16, 1997
Date of Patent:
October 12, 1999
Assignees:
Novo Nordisk A/S, Novo Nordisk Biotech, Inc.
Inventors:
Claus Fuglsang, Karen Oxenb.o slashed.ll, Torben Halkier, Randy M. Berka, Joel Cherry
Abstract: A process for expression of a protein product in Aspergillus oryzae is disclosed. The process comprises transforming Aspergillus oryzae with a vector system comprising DNA sequences encoding functions facilitating gene expression, a suitable marker for selection of transformants, and a DNA sequence encoding the desired protein product. The process enables industrial production of many different polypeptides and proteins in A. oryzae. Examples of such products are chymosin or prochymosin and other rennets, proteases, lipases and amylases. Also disclosed is an effective promoter for expression of a protein in Aspergillus. A preferred promoter is the TAKA-amylase promoter or functional parts thereof. There is also provided a process for the production of a recombinant Humicola lipase. The recombinant Humicola lipase from A. oryzae differs from the native lipase in having a greater glycosylation and in exhibiting an improved thermostability.
Abstract: A gel for cleaning hard surfaces that is formed by mixing water and a detergent composition comprising (i) a first surfactant, wherein the first surfactant is an amine oxide or a betaine or a tetraalkylammoniumchloride, and (ii) a second surfactant, wherein the second surfactant is an alkali metal salt of a fatty acid together with Na.sup.+ from NaCl, wherein the ratio of the first surfactant and the second surfactant is 1:10-10:1, (b) water, wherein said detergent composition is mixed with a sufficient amount of water to induce a phase change from a liquid phase to a gel phase, wherein a gel is formed having a surfactant concentration in the range of 0.1-25%, and (c) one or more enzymes.
Type:
Grant
Filed:
November 3, 1995
Date of Patent:
October 12, 1999
Assignee:
Novo Nordisk A/S
Inventors:
Poul N.o slashed.rgaard Christensen, Bo Kalum, Otto Andresen
Abstract: This invention relates to activation of enzymes. More specifically, the invention relates to agents capable of enhancing the activity of peroxidases or peroxidase acting compounds. The invention also relates to methods of oxidizing a substrate with a source of hydrogen peroxide in the presence of a peroxidase enzyme or a peroxidase acting compound, and an enhancing agent. More specifically, the invention relates to a method of bleaching of dye in solutions, to a method of inhibiting the transfer of a textile dye from a dyed fabric to another fabric when said fabrics are washed together in a wash liquor, to a method of bleaching of lignin-containing material, in particular bleaching of pulp for paper production, to a method of treatment of waste water from pulp manufacturing, and to a method of enzymatic polymerization and/or modification of lignin or lignin containing material.
Abstract: The present invention relates to novel N-substituted amino acids and esters thereof in which a substituted alkyl chain forms part of the N-substituent or salts thereof, to methods for their preparation, to compositions containing them, and to their use for the clinical treatment of painful, hyperalgesic and/or inflammatory conditions in which C-fibers play a pathophysiological role by eliciting neurogenic pain or inflammation.
Type:
Grant
Filed:
March 28, 1996
Date of Patent:
October 5, 1999
Assignee:
Novo Nordisk A/S
Inventors:
Peter Madsen, Knud Erik Andersen, Rolf Hohlweg, Florenzio Zaragossa Dorwald, Tine Krogh J.o slashed.rgensen, Uffe Bang Olsen, Henrik Sune Andersen
Abstract: The present invention relates to methods for producing heterologous heme proteins extracellularly comprising transforming a filamentous fungus with a vector comprising a DNA sequence encoding the heterologous heme protein and a DNA sequence encoding a preregion permitting secretion of the expressed heme protein, and culturing the transformed filamentous fungus in a suitable culture medium to produce the heme protein.
Type:
Grant
Filed:
May 20, 1997
Date of Patent:
September 28, 1999
Assignee:
Novo Nordisk A/S
Inventors:
Henrik Dalb.o slashed.ge, Ejner Bech Jensen, Karen Gjesing Welinder
Abstract: The present invention provides R(-)-N-(4,4-di(3-methylthien-2-yl)but-3-enyl)-nipecotic acid hydrochloride in its pure and stable anhydrous form.
Type:
Grant
Filed:
June 10, 1997
Date of Patent:
September 28, 1999
Assignee:
Novo Nordiskials
Inventors:
Preben Ahrndt, Henning B.o slashed.rge Petersen, Vincent H. Chang, Kimberly Ann Allen, Michael H. Cain
Abstract: In vivo assays for selecting candidate therapeutics for inhibiting amyloidoses, such as congophilic and fibrillar .beta./A4 amyloid deposition in brain. A candidate reagent is administered to a first rat in a first infusate comprising .beta./A4 peptide and perlecan by continuous infusion into the hippocampus for at least one week. The candidate reagent is selected as a candidate therapeutic for inhibiting congophilic and fibrillar .beta./A4 amyloid deposition in brain if the first infusate diminishes congo red and thioflavin S staining indicative of amyloid deposition adjacent to the infusion site, as compared with a second rat receiving a second infusate consisting essentially of .beta./A4 peptide and perlecan.
Type:
Grant
Filed:
June 5, 1995
Date of Patent:
September 28, 1999
Assignee:
Board of Regents of the University of Washington Office of Technology
Abstract: The present invention relates to Aspergillus oryzae 5-aminolevulinic acid synthases and isolated nucleic acid fragments comprising nucleic acid sequences encoding the 5-aminolevulinic acid synthases as well as nucleic acid constructs, vectors, and recombinant host cells comprising the nucleic acid sequences. The invention also relates to methods of producing the 5-aminolevulinic acid synthases.
Abstract: This invention relates to a method of forming localized variation of color density in the surface of a dyed cellulosic fabric, and to a composition for use in the method.
Type:
Grant
Filed:
March 2, 1998
Date of Patent:
September 28, 1999
Assignee:
Novo Nordisk A/A
Inventors:
Masahiro Onishi, Merete Fich, Annette Hanne Toft, Martin Schulein
Abstract: The present invention relates to methods for modifying the production of a polypeptide, comprising: (a) introducing a nucleic acid construct into a cell, wherein the cell comprises a DNA sequence encoding a polypeptide, under conditions in which the nucleic acid construct integrates into the genome of the cell at a locus not within the DNA sequence encoding the polypeptide to produce a mutant cell, wherein the integration of the nucleic acid construct modifies the production of the polypeptide by the mutant cell relative to the cell when the mutant cell and the cell are cultured under the same conditions; and (b) identifying the mutant cell with the modified production of the polypeptide.
Type:
Grant
Filed:
September 12, 1997
Date of Patent:
September 28, 1999
Assignee:
Novo Nordisk Biotech, Inc
Inventors:
Howard Brody, Deborah S. Yaver, Michael Lamsa, Kim Hansen
Abstract: In a displacement system for controlled infusion of a liquid from a cartridge comprising a tubular vessel (1), which is at a rear end closed by a piston (3) which may be forced by a piston rod (8) moving into the vessel (1) in the axial direction thereof to press out the liquid through an outlet (2) arranged at a front end of the vessel (1), the piston rod (8) is provided as a flexible incompressible construction which is by a piston rod guide (9) behind the rear end of the cartridge deflected away from the axis of this cartridge, preferably 180.degree.. The piston rod guide (9) has a guiding track comprising a curved part and linear parts at each end of the curved part ensuring that the piston rod is guided along a length (a) in the direction of the axis of the cartridge which length (a) is longer than the distance (b) between the two axes of the piston rod parts projecting from the piston rod guide.
Type:
Grant
Filed:
August 29, 1996
Date of Patent:
September 28, 1999
Assignee:
Novo Nordisk A/S
Inventors:
Jens Ulrik Poulsen, Henrik Ljunggreen, Henning Munk Ejlersen, Jens Munk, Lars Peter Klitmose, Preben Broskov Nielsen, S.o slashed.ren Mikkelsen, Jens M.o slashed.ller-Jensen, Anders Heger